Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection

NCT04509999 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No patients enrolled and funding withdrawn

Conditions

COVID-19

Interventions

DRUG: Bicalutamide 150 Mg Oral Tablet
DRUG: Placebo

Sponsor

University of Florida